Back to search

Article

TMEM33 deletion potentiates anti-tumor CD8 <sup>+</sup> T cell immunity

2026-01-02

Abstract excerpt

<h4>ABSTRACT</h4> Improving responses to cancer immunotherapies requires deeper insight into the cellular mechanisms governing T cell-mediated anti-tumor immunity. TMEM33 is an endoplasmic reticulum-resident transmembrane protein enriched across multiple tumor types, with reported functions in anti-viral immunity as well as calcium and lipid homeostasis, yet its role in tumor immunosurveillance remains unknown. U...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
efe2ecd9-4821-5660-9193-89a3df5494a2
DOI
10.64898/2026.01.01.697288
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TMEM33 deletion potentiates anti-tumor CD8 <sup>+</sup> T cell immunityDOI 10.64898/2026.01.01.697288
Select a neighboring publication to make it the new centre.